Pharmaceuticals
The pipeline of new drugs under development by the
pharmaceutical industry has come under more scrutiny during the
last decade than ever in the history of the industry. Health care
reform, increased competition, and stricter enforcement guidelines
by stricter government enforcement have placed increased pressure
on the ability of pharmaceutical companies to develop new drugs, to
bring them to market and to profit from their sale. As a result,
investment in new technology, the licensing of new compounds and
the consolidation of the industry have become dominant topics of
conversation in pharmaceutical company boardrooms.
Our team of pharmaceutical lawyers have been
involved in some of the most important drug development
transactions, patent cases, financings and licensing
transactions of the last 25 years. Our approach leverages the
firm’s expertise and experience across multiple practice groups and
related industry areas to meet the specific needs of our diverse
clients.
Areas of Focus:
- Venture Capital
- Incubation/acceleration services
- Intellectual Property assessment and
strategy
- Intellectual Property Litigation
- Patent and IT Licensing
- Strategic advisory/Mergers and
Acquisitions
- Corporate Governance
- Grants and legislative strategies
- IPOs/Capital Markets
- Government Relations and Public Policy
- Coverage and Reimbursement
- Fraud and Abuse and Corporate Compliance
- Clinical Research and Clinical Trials